Browse By: Country ι Category ι Tag
Home  »  Therapeutic Area

Therapeutic Area Market Research Reports

More

Natural Killer Cells Therapies - Competitive Landscape,Technology and Pipeline Analysis, 2017
The report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell based therapies and drugs that augment (enhance or activate) the NK cells. The report provides in-depth analysis on the Natural Killer Cell based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, technologies and targeted antigens. The report provides the NK Cell based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Reports Highlights: NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies. Collaborations & partnering deals Current Prominent Research Areas
Published Date: Apr 2017
Published By: DelveInsight

Price: $2450
Global Therapeutic Drug Monitoring Market 2017-2021
About Therapeutic Drug Monitoring Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, demographic, and clinical information. It also considers a posteriori measurement of drug concentration in the blood. Technavio’s analysts forecast the global therapeutic drug monitoring market to grow at a CAGR of 7.5% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global therapeutic drug monitoring market for 2017-2021.
Published Date: Apr 2017
Published By: Technavio

Price: $3500
Global Nitric Oxide Therapy System Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nitric Oxide Therapy System for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Nitric Oxide Therapy System market competition by top manufacturers/players, with Nitric Oxide Therapy System sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including INOMAX? Praxair DATEX-OHMEDA EKU Elektronik International Biomedical ... On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth r
Published Date: Apr 2017
Published By: QYResearch

Price: $4000
Global Bipolar Disorder Therapeutic Market 2017-2021
Bipolar disorder, also called manic-depressive disorder, is a mental disorder that causes unusual mood swings in patients. The disease causes periods of depression and mania in patients. Technavio’s analysts forecast the global bipolar disorder therapeutic market to grow at a CAGR of 2.22% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global bipolar disorder therapeutic market for 2017-2021. To calculate the market size, the report considers the sales of drugs in the bipolar disorder therapeutic market. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Bipolar Disorder Therapeutic Market 2017-2021, has been prepared based on an
Published Date: Apr 2017
Published By: Technavio

Price: $3500
EMEA (Europe, Middle East and Africa) Therapeutic Nuclear Medicines Market Report 2017
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume (MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Cardinal Health Mallkrodt Plc GE Healthcare Lantheus Medical Imaging Bayer AG Bracco Imaging SpA Eczacibasi-Monrol Nuclear Products Nordion Advanced Accelerator Appli
Published Date: Mar 2017
Published By: QYResearch

Price: $4000
Global Antifungal Agents Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antifungal Agents in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Antifungal Agents market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Asperqillus Alternaria Abbott Laboratories Pfizer Glaxosmithkline Bayer Healthcare Novartis Sanofi-Aventis Merck & Co. Kramer Laboratories Enzon Pharmaceuticals Gilead On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Echinocandins Azoles Ployenes Allylam
Published Date: Mar 2017
Published By: QYResearch

Price: $2900
Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers
The untapped market of proton therapy in Russia would be more than US$ 3 Billion during forecast period. IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, has started installation of the Cyclone® 230 in 2016 for a new proton therapy center. The acceptance of the first treatment room is planned for the end of 2017. The proton therapy center in Dimitrovgrad will be IBA’s first in the Russian Federation and is expected to treat up to 1,200 patients per year according to IBA.   
Published Date: Mar 2017
Published By: Renub Research

Price: $1150
EMEA (Europe, Middle East and Africa) Varicose Veins Treatment Devices Market Report 2017
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Varicose Veins Treatment Devices for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Varicose Veins Treatment Devices market competition by top manufacturers/players, with Varicose Veins Treatment Devices sales volume (Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Syneron Candela Covidien AngioDynamics Alna-Medicalsystem GmbH Asclepion Laser Technologies Cooltouct WONTechnology LINLINE Medical Systems GIGAALASE
Published Date: Mar 2017
Published By: QYResearch

Price: $4000
United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers
The potential market of proton therapy in United States would be more than US$ 15 Billion by the end of 2021 and it is expected to grow with a CAGR of 6.04 percent in future. At present United States holds world’s 40 percent of Proton Beam Therapy Facility. In the recent time, more research institutes and hospitals are investing in proton therapy to make the technology more accessible to patients.
Published Date: Mar 2017
Published By: Renub Research

Price: $1200
Italy Proton Therapy Market, Patients Treated at Proton Therapy Centers & Forecast
Proton Therapy Market in Italy would double by the end of 2021 from its market in 2016. There are currently three proton therapy centers in Italy that significantly increases their capacity to treat more patients. In Italy the first patients were treated with proton beams in 2002 at the INFN-LNS, Catania.  Rising significant cancer incidence in Italy will further enhance the proton therapy market of Italy.
Published Date: Mar 2017
Published By: Renub Research

Price: $1150
Proton Therapy Market in Switzerland, Reimbursement Policy, Patients Treated at Proton Facility & Forecast
Switzerland has one of the old proton therapy centers in Europe and was established in 1984 and there are so many recommended proton therapy patients from other parts of Europe coming for their treatment. The old proton therapy center at CPT, PSI, Villigen was further renovated with technological advancement in 2010 and again in 2013. Switzerland Proton Therapy Market is expected to grow thrice from its present market in 2016. 
Published Date: Mar 2017
Published By: Renub Research

Price: $1150
Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast
Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast is a research study published by Renub Research. According to this research South Korea Proton Therapy Market is expected to almost triple by 2021 from its current market size in 2016. Untapped Proton Therapy Market for South Korea was more than 1 Billion USD in period of 2016. Proton Therapy plays an important role in delivering comprehensive cancer care to children and adults at the National Cancer Center of Korea (KNCC, IIsan). 
Published Date: Mar 2017
Published By: Renub Research

Price: $1150
United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast
United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast is a research study published Renub Research. UK Proton Therapy Market is expected to grow with a CAGR of 82% in future. United Kingdom Proton Therapy Market is expected to grow 10 times from its current market in 2016. Currently UK has only one Proton Therapy facility, at Clatterbridge cancer center and it’s a ‘low-energy’ machine, only suitable for treating people with rare eye cancers. 
Published Date: Feb 2017
Published By: Renub Research

Price: $1150
Global Magnesium Salicylate Market Research Report 2017
Production, means the output of Magnesium Salicylate Revenue, means the sales value of Magnesium Salicylate This report studies Magnesium Salicylate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Cigna New Roots Herbal ... Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Magnesium Salicylate in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided
Published Date: Feb 2017
Published By: QYResearch

Price: $2900
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities
The field of oncolytic viruses was quite dormant in the first decade of the 2000s, characterized by slow clinical progress due to hypercautiousness and low, albeit steady, investments. The takeover of BioVex by Amgen in late 2011, worth up to US$ 1 bln, has woken up the field and became a game changer together with the 2015 approval of the first oncolytic virus Imlygic developed by BioVex in regulated markets. In addition, it was increasingly recognized that oncolytic viruses not only were able to directly lyse cancer cells, but they also „freed“ tumor specific neoantigens, indirectly acting as a cancer vaccine.
Published Date: Jan 2017
Published By: La Merie Publishing

Price: $2400
Europe Uterine Fibroids Treatment Market Report 2017
This report studies sales (consumption) of Uterine Fibroids Treatment in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Published Date: Jan 2017
Published By: QYResearch

Price: $3900
China Uterine Fibroids Treatment Market Research Report 2017
This report studies Uterine Fibroids Treatment in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Published Date: Jan 2017
Published By: QYResearch

Price: $3200
Global Pruritus Therapeutics Market Research Report 2016
Production, means the output of Pruritus Therapeutics Revenue, means the sales value of Pruritus Therapeutics This report studies Pruritus Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Brunswick Corporation Johnson Health Tech Co. Ltd Nautilus Strength Icon Health & Fitness Amer Sports Technogym Precor incorporated Cybex International Inc Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Pruritus Therapeutics in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast A
Published Date: Jan 2017
Published By: QYResearch

Price: $2900
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. COPD occurs most often in older people, but can also affect people in their middle ages. It is a major cause of chronic morbidity and mortality globally. Many people suffer from this disease for years, and die from it or its complications, and it constitutes a substantial economic and social burden.
Published Date: Jan 2017
Published By: GBI Research

Price: $4995
Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020)
The report titled “Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020)” provides an in-depth analysis of the global AAT Replacement Therapy market with detailed analysis of market sizing, growth and market share. The report provides market size by value and volume along with the supply trend prevailing in the market. The report provides detail market analysis of the major products available in the market for treating AAT deficiency. The four major products included are, Prolastin, Glassia, Zemaira, and Aralast. Among which, Prolastin had the monopoly in the market for over 25 years, Asit was the first AAT Replacement Therapy available in the market for the treatement. The report also assesses the key opportunities in the market and out
Published Date: Dec 2016
Published By: Daedal Research

Price: $800

Back To Top